Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:23:20.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page with the standard header and footer, replacing expected content and including a Home link. This indicates the page cannot be loaded as intended.
    Difference
    0.5%
    Check dated 2026-09-29T22:20:54.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating that access to the record is blocked and the standard header/footer are displayed as part of the error page.
    Difference
    20%
    Check dated 2026-09-22T23:05:30.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision tag at the bottom updated from v3.6.6 to v3.7.0, indicating a new version of the ClinicalTrials.gov interface deployment. This change does not affect study data or content.
    Difference
    0.0%
    Check dated 2026-09-15T21:59:35.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears, replacing the previous v3.6.5. This is a minor update to the page metadata and does not modify any study content.
    Difference
    0.0%
    Check dated 2026-09-01T19:48:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removal of the Melanoma entry, the related topics header, and the MedlinePlus Genetics link from the related topics section, reducing cross-links to external topics.
    Difference
    0.1%
    Check dated 2026-08-25T20:58:21.000Z thumbnail image

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.